Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer

Michael G. Heckman, Alexander S. Parker, Kevin J. Wu, Tracy W. Hilton, Stephen J. Ko, Thomas M. Pisansky, Steven E. Schild, Li Yan Khor, Elizabeth H. Hammond, Alan Pollack, Steven J. Buskirk

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences